Yiheng Capital Management L P's Q4 2024 13F: 2 new positions

Form 13F-HR for the quarter ended Dec 31, 2024 · filed Feb 11, 2025 · 19 reported positions · accession 0001941040-25-000114

What changed this quarter

Yiheng Capital Management L P's changes in reported equity positions, Q4 2024
Activity Security Weight before Weight now Change Shares Shares %
Reduced BILIBILI INC (BILI) 27.3% 19.7% −7.7 pts −1.42M sh −22%
New MOBILEYE GLOBAL INC (MBLY) — 3.3% +3.3 pts +750K sh new
Reduced H WORLD GROUP LTD (HTHT) 11.0% 9.5% −1.5 pts −298K sh −19%
Reduced BEAM THERAPEUTICS INC (BEAM) 3.5% 2.3% −1.1 pts −338K sh −44%
Increased ATRENEW INC (RERE) 0.8% 2.0% +1.2 pts +1.64M sh +108%
Increased ROBLOX CORP (RBLX) 4.1% 7.3% +3.3 pts +72,882 sh +15%
Reduced AKERO THERAPEUTICS INC (AKRO) 4.0% 4.1% +0.1 pts −92,624 sh −12%
Increased DENALI THERAPEUTICS INC (DNLI) 3.2% 3.2% −0.1 pts +100K sh +17%
Reduced VIRIDIAN THERAPEUTICS INC (VRDN) 3.6% 3.2% −0.4 pts −97,630 sh −12%
Increased ACM RESH INC (ACMR) 2.5% 2.3% −0.2 pts +14,300 sh +2%
New YATSEN HLDG LTD (YSG) — 0.0% 0.0 pts +10,508 sh new

Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled

† Security identifier (CUSIP) changed — read as one continuing position, not an exit and a new position:

  • DBV TECHNOLOGIES S A (DBVT): 23306J200 → 23306J309, 3.15M → 656K shares (share count changed with the identifier; not shown as a trade)

Top 10 positions — 88.4% of the equity book

Changes in the top 10 this quarter: MBLY entered · BEAM left

# Security Weight before Weight now
1 BILIBILI INC (BILI) 27.3% 19.7%
2 NOAH HLDGS LTD (NOAH) 15.3% 17.4%
3 JD.COM INC (JD) 11.2% 11.6%
4 H WORLD GROUP LTD (HTHT) 11.0% 9.5%
5 NEW ORIENTAL ED & TECHNOLOGY (EDU) 7.3% 7.4%
6 ROBLOX CORP (RBLX) 4.1% 7.3%
7 TAL EDUCATION GROUP (TAL) 4.8% 4.9%
8 AKERO THERAPEUTICS INC (AKRO) 4.0% 4.1%
9 MOBILEYE GLOBAL INC (MBLY) 0.0% 3.3% Entered the top 10
10 VIRIDIAN THERAPEUTICS INC (VRDN) 3.6% 3.2%
— BEAM THERAPEUTICS INC (BEAM) 3.5% 2.3% Left the top 10

Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).

Option positions (puts and calls)

Reported separately from the positions above. The value a 13F reports for an option is that of the underlying shares, not the option itself.

Activity Security Type Shares before Shares now Reported value
Increased JD.COM INC (JD) Call 18.94M 38.47M $1.33B
New ASTERA LABS INC (ALAB) Put 0 818K $108M
New SUPER MICRO COMPUTER INC (SMCI) Put 0 900K $27.4M
Increased BILIBILI INC (BILI) Call 27.74M 37.32M $676M